Context Antimicrobial resistance (AMR) is one of the leading causes of death worldwide: in 2019, approximately 4.95 million deaths were attributable to infections with resistant bacteria. AMR-EFFECT builds directly on its GHPP-predecessor project, WHOCC-AMR, addressing the global challenges of AMR and healthcare-associated infections (HAI). It focuses on the analysis of…
Context Antimicrobial resistance occurs when antibiotics lose their effectiveness against bacterial infections. It is a growing public health concern, particularly in sub-Saharan Africa. Key contributing factors include uncontrolled access to antibiotics, inappropriate use in human and animal medicine, and limited access to laboratory-based diagnostics. Many rural areas lack adequate laboratory…
Context In many countries in Western and South-Eastern Africa, access to safe and effective medicines remains a challenge. A key factor is the limited capacity of national drug quality control laboratories. Insufficient structures, resources or standardised procedures hinder reliable quality testing. As a result, substandard or falsified medicines may reach…